Form 4 for EXEL EXELIXIS, INC.
Accepted 2023-01-09 00:00:00 ET · period of report 2023-01-05 · accession 0000939767-23-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-09 | 2023-01-05 | EXEL | Aftab Dana | CSO, EVP Disc, Trans Research | A - Grant | $0.00 | +100.0K | 353.0K | +40% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-05 | A | A | 100,000 | $0.00 | 353,001 | D | — | — | (F1) Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. (F2) The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Subject to the terms of the restricted stock unit award, the restricted stock units will vest as follows: 25,000 on February 15, 2024 and, thereafter, 25,000 on each of February 15, 2025, 2026 and 2027. (F3) Includes 213,838 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. |